Polypharmacy, multiple natural health products and hepatotoxicity

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 14, 2011, Pages

  Cvijovic, Kosta ^a,b   Boon, Heather ^a   Jaeger, Walter ^b   Vohra, Sunita ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BUDESONIDE PLUS FORMOTEROL FUMARATE; CONJUGATED LINOLEIC ACID; DIMETHYL SULFONE; DIURETIC AGENT; ESTRADIOL; FISH OIL; HUMAN GROWTH HORMONE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTULOSE; LINSEED OIL; LORAZEPAM; MULTIVITAMIN; NATURAL PRODUCT; PREDNISONE; PROBIOTIC AGENT; PROGESTERONE; RETINOL; THIOCTIC ACID; UBIDECARENONE; UNINDEXED DRUG; VARENICLINE; VENLAFAXINE; VITAMIN D;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ASCITES; ASTHMA; CASE REPORT; DEPRESSION; DIFFERENTIAL DIAGNOSIS; FATIGUE; FEMALE; FLAPPING TREMOR; HEPATIC ENCEPHALOPATHY; HOSPITAL READMISSION; HUMAN; HUMAN TISSUE; JAUNDICE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER NECROSIS; LIVER TOXICITY; POLYPHARMACY;

EID: 80053557786     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.091948     Document Type: Article

References (20)

1. Franck AJ, Sliter LR. Acute hepatic injury associated with varenicline in a patient with underlying liver disease. Ann Pharmacother 2009;43:1539-43.
2. Sencan I, Sahin I, Ozcetin A. Low-dose venlafaxine-associated liver toxicity in chronic hepatitis [letter]. Ann Pharmacother 2004;38:352-3. (Pubitemid 38112256)
3. Horsmans Y, De Clereq M, Sempeux C. Venlafaxine-associated hepatitis [letter]. Ann Intern Med 1999;130:944.
4. Ramos R, Mascarenhas J, Duarte P, et al. Conjugated linoleic acid-induced toxic hepatitis: first case report. Dig Dis Sci 2009;54:1141-3.
5. Leekumjorn S, Wu Y, Sum AK, et al. Experimental and computational studies investigating trehalose protection of HepG2 cells from palmitate-induced toxicity. Biophys J 2008;94:2869-83.
6. Rauen U, Klempt S, De Groot H. Histidine-induced injury to cultured liver cells, effects of histidine derivatives and of iron chelators. Cell Mol Life Sci 2007;64:192-205. (Pubitemid 46155699)
7. Scarna A, Gijsman HJ, McTavish SF, et al. Effects of a branchedchain amino acid drink in mania. Br J Psychiatry 2003; 182:210-3. (Pubitemid 36286733)
8. Garlick PJ. The nature of human hazards associated with excessive intake of amino acids. J Nutr 2004;134:1633S-9S. (Pubitemid 38720752)
9. Hamid S, Rojter S, Vierling J. Protracted cholestatic hepatitis after the use of prostata. Ann Intern Med 1997;127:169-70. (Pubitemid 27337412)
10. Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: Adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr 1999;69:1071-85. (Pubitemid 29252039)
11. Kitano M, Watanabe D, Oda S, et al. Subchronic oral toxicity of ubiquinol in rats and dogs. Int J Toxicol 2008;27:189-215. (Pubitemid 351522767)
12. Ritskes-Hoitinga J, Verschuren PM, Meijer GW, et al. The association of increasing dietary concentrations of fish oil with hepatotoxic effects and a higher degree of aorta atherosclerosis in the ad lib.-fed rabbit. Food Chem Toxicol 1998;36:663-72. (Pubitemid 28369894)
13. Cvijovic K, Boon H, Brulotte J, et al. Pharmacy study of natural health product adverse reactions (SONAR): piloting an active surveillance model in community pharmacies. [abstract]. Pharmaceut Biol 2009;47(Suppl 1):21.
14. Alvarez-Requejo A, Carvajal A, Begaud B, et al. Under - reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol 1998;54:483-8. (Pubitemid 28418817)
15. Fallon MB, Boyer JL. Hepatic toxicity of vitamin A and synthetic retinoids. J Gastroenterol Hepatol 1990;5:334-42. (Pubitemid 20375195)
16. The Global Intelligence Network for Benefits and Risks in Medicinal Products. Causality assessment of suspected adverse reactions. Uppsala (Sweden): Uppsala Drug Monitoring Centre - WHO Collaborating Centre for International Drug Monitoring.
17. Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 2007;41:674-80. (Pubitemid 46625492)
18. Smith JW, Seidl LG, Cluff LE. Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. Ann Intern Med 1966;65:629-40.
19. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. (Pubitemid 12149145)
20. Bailey DG, Dresser GK. Natural products and adverse drug interactions. CMAJ 2004;170:1531-2. (Pubitemid 38686180)